Difference between revisions of "Medical Reporting/Vaccine and Treatment News"
Jump to navigation
Jump to search
(Created page with "= Medical Reporting and Research = == Citations outside of the CDC and WHO == == Minimal Requirement of being a verified major news outlet with a high unbiased rating on [htt...") |
|||
| Line 1: | Line 1: | ||
= Medical Reporting and Research = | = Medical Reporting and Research = | ||
| − | + | ||
| − | == Minimal Requirement of being a verified major news outlet with a high unbiased rating on [https://www.adfontesmedia.com/?v=402f03a963ba The Media Bias Chart] == | + | == Minimal Requirement of being a verified major news outlet with a high unbiased rating on [https://www.adfontesmedia.com/?v=402f03a963ba The Media Bias Chart] and/or from reputable sources, such as research facilities and universities == |
'''Strong recommendation to not take action or make assumptions based upon research which may be dated, changing or part of ongoing research''' | '''Strong recommendation to not take action or make assumptions based upon research which may be dated, changing or part of ongoing research''' | ||
| Line 7: | Line 7: | ||
* [https://pubmed.ncbi.nlm.nih.gov/26133021/ Brief Report: Incubation Period Duration and Severity of Clinical Disease Following Severe Acute Respiratory Syndrome Coronavirus Infection] | * [https://pubmed.ncbi.nlm.nih.gov/26133021/ Brief Report: Incubation Period Duration and Severity of Clinical Disease Following Severe Acute Respiratory Syndrome Coronavirus Infection] | ||
**Conclusions: Our findings suggest that patients with a shorter incubation period went on to have more severe disease. Further studies are needed to investigate potential biological mechanisms for this association. | **Conclusions: Our findings suggest that patients with a shorter incubation period went on to have more severe disease. Further studies are needed to investigate potential biological mechanisms for this association. | ||
| + | * [https://inside.mountsinai.org/blog/mount-sinai-to-begin-the-transfer-of-covid-19-antibodies-into-critically-ill-patients/?fbclid=IwAR2CcXcdOujkVZLtKMjLBDCKDk45lue7h6F7yTu9JO0UB87QtLSqF3-mQp8 Mount Sinai to Begin the Transfer of COVID-19 Antibodies into Critically Ill Patients] - The Mount Sinai Health System this week plans to initiate a procedure known as plasmapheresis, where the antibodies from patients who have recovered from COVID-19 will be transferred into critically ill patients with the disease, with the expectation that the antibodies will neutralize it. | ||
Revision as of 11:06, 27 March 2020
Medical Reporting and Research
Minimal Requirement of being a verified major news outlet with a high unbiased rating on The Media Bias Chart and/or from reputable sources, such as research facilities and universities
Strong recommendation to not take action or make assumptions based upon research which may be dated, changing or part of ongoing research
- Brief Report: Incubation Period Duration and Severity of Clinical Disease Following Severe Acute Respiratory Syndrome Coronavirus Infection
- Conclusions: Our findings suggest that patients with a shorter incubation period went on to have more severe disease. Further studies are needed to investigate potential biological mechanisms for this association.
- Mount Sinai to Begin the Transfer of COVID-19 Antibodies into Critically Ill Patients - The Mount Sinai Health System this week plans to initiate a procedure known as plasmapheresis, where the antibodies from patients who have recovered from COVID-19 will be transferred into critically ill patients with the disease, with the expectation that the antibodies will neutralize it.
